Clinical Trials

Breast Cancer Invasive

NCT00182728 2024-10-01

NRR

Phase NA Completed

89 enrolled 10 charts

Phase 2 Active not recruiting

Breast Neoplasms, Carcinoma, Ductal, Breast

NCT04997941 2024-04-23

MORE-T

238 enrolled

Premenopausal Breast Cancer

NCT05809128 2024-03-25

Multidisciplinary Approach to Breast Cancer Through the Study of Altered Transcriptomic and Immune Accompanied by the Identification of Extractable Markers From the Radiodiagnostic Bioimaging

1,000 enrolled

Phase 3 Active not recruiting

Breast Cancer Patients

NCT03595592 2024-03-06

APTneo

650 enrolled

BreastGastrointestinalGynecologicOther solid neoplasmThoracic

Invasive Breast Cancer

NCT06281860 2024-02-28

PITHAC

Phase 1 Unknown

39 enrolled

Mesothelioma, Malignant, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms, Ovarian Neoplasms, Stomach Neoplasms

NCT01717131 2024-01-11

Axillary Node Dissection Versus no Dissection in Breast Cancer With Positive Sentinel Lymph Node

Phase NA Active not recruiting

2,228 enrolled

Invasive Breast Cancer

NCT06121557 2023-11-08

Phase I Study of Autologous Tumor-Draining Lymph Node-Derived Lymphocytes for Advanced HER2-Negative Breast Cancer

Phase 1 Recruiting

24 enrolled

Breast Neoplasms

NCT05981001 2023-08-08

Study of Autologous Tumor-Draining Lymph Node-Derived Lymphocytes for Advanced HER2-Negative Breast Cancer

Phase 1/2 Recruiting

170 enrolled

Breast Neoplasms

NCT02891759 2023-05-06

Compare Outcomes Between Two Acellular Dermal Matrices

320 enrolled

Phase NA Active not recruiting

Breast Neoplasms

NCT02400658 2023-01-25

Efficacy of IORT With CT-Guided HDR Brachytherapy for Treatment of Breast Cancer

358 enrolled

Breast Neoplasms

NCT05680194 2023-01-11

EEBC

1,000 enrolled

Breast Neoplasms

NCT04698252 2022-08-08

LARA

Phase 2 Recruiting

74 enrolled

Phase 2 Active not recruiting

Breast Neoplasms

NCT04398914 2022-03-31

Pyrotinib, Trastuzumab, Pertuzumab and Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer

216 enrolled

Breast Cancer Invasive

NCT01847001 2021-09-10

Study of Propranolol in Newly Diagnosed Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy

10 enrolled 12 charts

Breast Neoplasms

NCT04750018 2021-02-11

Influence of Co-Vid 19 Pandemic on Screening Mammography Single Institution

600 enrolled

COVID-19, Breast Neoplasms

NCT00574587 2020-10-14

Trial for Locally Advanced Breast Cancer Using Vorinostat Plus Chemotherapy

Phase 1/2 Completed

55 enrolled 10 charts

Phase EARLY_PHASE1 Completed

Breast Neoplasms

NCT02900469 2020-08-21

Presurgical Trial of Denosumab in Breast Cancer

44 enrolled

Breast Neoplasms

NCT03183206 2020-07-13

Safety and Efficiency of γδ T Cell Against Breast Cancer

Phase 1/2 Completed

100 enrolled

Breast Neoplasms

NCT04066790 2020-05-19

Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer

Phase 2 Terminated

12 enrolled

Breast Neoplasms

NCT02251353 2020-02-21

IMET

300 enrolled

Breast Neoplasms, Neoplasm Metastasis

NCT04086394 2020-02-20

PECS

Phase NA Unknown

130 enrolled

Breast Neoplasms, Pain, Pain, Postoperative

NCT02125630 2019-07-31

Bone Metastasis and Surgery in Breast Cancer

Completed

460 enrolled

Breast Neoplasms

NCT00944047 2018-04-23

Evaluate Trastuzumab Plus Standard Chemotherapy Given Before Surgery in Breast Cancer Patients With Low HER 2 Expression

32 enrolled 7 charts

Breast Neoplasms

NCT01009437 2017-12-05

Ritonavir and Its Effects on Biomarkers in Women Undergoing Surgery for Newly Diagnosed Breast Cancer

Phase 1 Completed

28 enrolled

Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating, Triple Negative Breast Neoplasms

NCT00855114 2017-12-02

Everolimus in Treating Women With Breast Cancer That Can Be Removed by Surgery

Phase 2 Withdrawn

Breast Neoplasms

NCT00450723 2017-02-07

Thoracoscopic Sentinel Lymph Node Biopsy in Patients With Stage I or Stage II Breast Cancer

Phase NA Completed

39 enrolled 6 charts

Breast Neoplasms, Breast Neoplasms, Male

NCT00820690 2015-08-05

LABC

80 enrolled

Breast Neoplasms

NCT01368263 2015-04-03

Goserelin and Letrozole or Anastrozole in Premenopausal Patients With Stage II-III Estrogen Receptor-Positive Breast Cancer

Phase 2 Terminated

8 enrolled 5 charts

Breast Neoplasms

NCT00003050 2014-05-22

Radiation Therapy Plus Paclitaxel in Treating Patients With Stage IIB or Stage III Breast Cancer

46 enrolled

Breast Neoplasms

NCT00842465 2013-11-25

Prolacsein

Completed

735 enrolled

Breast Diseases, Breast Neoplasms, Cystic Fibrosis

NCT00082667 2013-02-25

Gefitinib Followed By Surgery in Treating Women With Ductal Carcinoma In Situ of the Breast

Phase 2 Terminated

1 enrolled

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

NCT00003953 2013-01-28

Chemotherapy Followed by Surgery in Treating Women With Stage II or Stage III Breast Cancer

39 enrolled

Breast Neoplasms

NCT00005800 2012-09-25

Doxorubicin and Docetaxel in Treating Women With Stage III Breast Cancer

45 enrolled

Breast Neoplasms, Inflammatory Breast Neoplasms

NCT00003035 2011-03-24

Doxorubicin and Paclitaxel in Treating Women With Locally Advanced Breast Cancer

40 enrolled